pipette
ENEnglish

Frequency of pharmacogenomic variation and medication exposures among participants in the All of Us Research Program

Andrew Haddad, Aparna Radhakrishnan, Sean R. McGee, Joshua D. Smith, Jason H. Karnes, Eric Venner, Marsha M. Wheeler, Karynne Patterson, Kimberly Walker, Divya Kalra, Sara E. Kalla, Qiaoyan Wang, Kathleen Polkowski, Richard A. Gibbs, Gail Pairitz Jarvik, Janeth I. Sanchez, Anjene Musick Addington, Andrea H. Ramirez, Joshua C. Denny, Philip E. Empey, Dmitry Abramov, Brian Ahmedani, Habib Ahsan, Hoda Anton-Culver, Maria Argos, Dave W. Arnold, Brisa Aschebook-Kilfoy, Katie Baca-Motes, Catherine Balthazar, Laura Bartlett, Gillian Bartlett‐Esquilant, Melissa Basford, Leland Baskin, Mark Begale, Eric Boerwinkle, Ingrid Bonilla-Mercado, Alexander Borowsky, Amaryllis Silva Boschetti, Matthew Breeden, Brad Bryan, Jessica Burke, Elizabeth Burnside, Lisa Cadmus-Bertram, Librada Callender, Roberta Carlin, Olveen Carrasquillo, Suchitra Chandrasekaran, Alexander Charney, Mine Cicek, Cheryl Clark y 10 más

Revista con revisión por paresUso en el mundo real

En palabras de los autores

Esta revista no permite republicar el resumen completo. Estas son las dos oraciones que eligió Pipette, citadas textualmente. El resto está en el sitio de la editorial.

Resultado principal
Importantly, we report thousands of previously unrecognized pharmacogene variants and hundreds of alleles and predicted phenotypes that deviate from known frequencies across populations or were previously unreported, especially in the Americas and African ancestry groups.

Apareció: viernes, 13 de noviembre. Science Translational Medicine. Revista con revisión por pares.

DOI: 10.1126/scitranslmed.adt8040